Coya therapeutics to participate in a fireside chat at the 7th annual evercore healthconx conference

Houston--(business wire)--coya therapeutics, inc. (nasdaq: coya) (“coya” or the “company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory t cell (treg) function, announces that chief executive officer arun swaminathan, ph.d. and executive chairman howard berman, ph.d. will participate in the 7th annual evercore healthconx conference being held on december 3 – 5, 2024 at the loews coral gables hotel in coral gables, fl. on tuesday, december 3 at 12:55.
EVR Ratings Summary
EVR Quant Ranking